Coetzee G A, Gevers W, van der Westhuyzen D R
Artery. 1980;7(1):1-15.
Plasmin, generated by the interaction of urokinase with plasminogen, degraded the apoprotein B moiety of human low density lipoprotein to yield distinct high moleculr weight intermediates under conditions where only a small fraction (less than 3%) of the protein was hydrolyzed to trichloroacetic acid-soluble products. The molecular weights of these intermediates were between 60 000 and 200 000 as estimated by SDS-polyacrylamide electrophoresis. Trypsin treatment yielded fragments of similar size to those obtained with plasmin. When enzyme-treated low density lipoproteins were added to bovine aortic smooth muscle cells in culture, the receptor-binding, and rates of internalization and degradation were no different from those obtained in the case of native low density lipoproteins.
由尿激酶与纤溶酶原相互作用产生的纤溶酶,在仅一小部分(小于3%)蛋白质被水解为三氯乙酸可溶产物的条件下,将人低密度脂蛋白的载脂蛋白B部分降解,产生不同的高分子量中间体。通过SDS-聚丙烯酰胺电泳估计,这些中间体的分子量在60000至200000之间。胰蛋白酶处理产生的片段大小与纤溶酶处理得到的相似。当将酶处理的低密度脂蛋白添加到培养的牛主动脉平滑肌细胞中时,其受体结合、内化和降解速率与天然低密度脂蛋白的情况没有差异。